Concepedia

M Misiek

MM

Statistics

Publications

17

Citations

582

H-Index

12

Active since

1955

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol Laboratories (United Kingdom)

M Misiek is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, microbiology, and antibiotic resistance.

ORCID

Publications per year

1955–2000

17

Publications

17

Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics

R E Kessler, M Bies, R. E. Buck et al. · Antimicrobial Agents and Chemotherapy · 1985 · 159 citations

, , +17

MICROBIOLOGICAL EVALUATION OF BB-K 8, A NEW SEMISYNTHETIC AMINOGLYCOSIDE

K. E. Price, D. R. GHISHOLM, M Misiek et al. · The Journal of Antibiotics · 1972 · 91 citations · Full text

, , +8

BMY 28100, a new oral cephalosporin

F. Leitner, T. A. Pursiano, R. E. Buck et al. · Antimicrobial Agents and Chemotherapy · 1987 · 62 citations

, , +13

Laboratory Evaluation of BL-S786, a Cephalosporin with Broad-Spectrum Antibacterial Activity

F. Leitner, M Misiek, T. A. Pursiano et al. · Antimicrobial Agents and Chemotherapy · 1976 · 48 citations · Full text

, , +17

BL-S 640, a Cephalosporin with a Broad Spectrum of Antibacterial Activity: Properties In Vitro

F. Leitner, R. E. Buck, M Misiek et al. · Antimicrobial Agents and Chemotherapy · 1975 · 38 citations · Full text

, , +14

1–5 of 17